Skip to content
Paul L. Feingold, M.D., M.H.S.

Paul L. Feingold, M.D., M.H.S.

Thoracic & Foregut Surgery , Surgery , Cancer

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-1509

Locations

Esophageal & Thoracic Surgery

601 Elmwood Avenue, 2nd Floor
Rochester, NY 14642

Wilmot Cancer Institute

155 Bellwood Drive
Rochester, NY 14606

About Me

“I am from New York city originally. I have lived in several places up and down the East Coast. I have a spouse that is in women’s health and two children that approach life with the same passion as their parents.”

Area of Expertise
• Thoracic Oncology
• Robotic Assisted Surgery
• En...
“I am from New York city originally. I have lived in several places up and down the East Coast. I have a spouse that is in women’s health and two children that approach life with the same passion as their parents.”

Area of Expertise
• Thoracic Oncology
• Robotic Assisted Surgery
• Endobronchial & Endoscopic Procedures
• Minimally Invasive Thoracic & Abdominal Surgery

Area of Special Interest
• Benign & Malignant Disease
• Translational Research
• Clinical Trials
• Translational Cancer Immunology

I was immediately drawn to thoracic and foregut surgery after my first exposure at Emory University. Since that time, my passion for this specialty has only intensified and I consider it a true calling. The field is rapidly growing and advancing. The ability to use minimally invasive techniques in combination with new medical treatments makes it a very exciting specialty to be a part of. I treasure the opportunity to have an immediate positive impact on my patients’ quality of life. I am excited to have the opportunity to use the latest tools and resources to treat both benign and malignant disease. We are lucky to be able to leverage all the resources available at URMC to advance our field and help our patients.

Ultimately, however, patients are at the center of what drew me into medicine, and into the specialty of thoracic surgery specifically. I get the most gratification out of taking a team approach to navigate towards the best possible outcomes for our patients. I consider it an honor to have the opportunity to treat patients with thoracic and foregut disease, and I look forward to exhausting every possible means to help patients achieve their goals.

Faculty Appointments

Assistant Professor - Department of Surgery, Thoracic (SMD)

Credentials

Residency & Fellowship

Fellowship, Thoracic Surgery, Brigham & Womens Hospital. 2020 - 2022

Residency, Resident, Yale New Haven Hospital. 2017 - 2020

Fellowship, Research, National Cancer Institute/National Institute of Health. 2014 - 2017

Residency, Surgery (General Surgery), Yale New Haven Hospital. 2013 - 2014

Internship, Surgery (General Surgery), Yale New Haven Hospital. 2012 - 2013

Education

MHS | Duke University School of Medicine. 2017

MD | Emory University. 2012

Publications

Journal Articles

Supporting The Use of Institutional Data to Improve Outcomes.

Feingold PL, Kennedy-Shaffer L, Wee J, Jaklitsch M, Marshall MB

The Annals of thoracic surgery.. 2023 October 10 Epub 10/10/2023.

Anastomotic Stricture After Minimally Invasive Esophagectomy.

Feingold PL, Bryan D, Kuckelman J, Kennedy-Shaffer L, Wang V, Deeb A, Wee J, Jaklitsch M, Marshall MB

The Annals of thoracic surgery.. 2023 May 24 Epub 05/24/2023.

Reply to R.A. Snyder et al.

Klemen ND, Feingold PL, Hashimoto B

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 August 140 (22):2512-2513. Epub 05/17/2022.

How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?

Klemen ND, Feingold PL, Hashimoto B

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 February 140 (4):320-323. Epub 12/06/2021.

Commentary: One Plus One Does Not Equal Two: Combined Pectus Repair With Open Cardiac Surgery.

Feingold PL, Marshall MB

Seminars in thoracic and cardiovascular surgery.. 2021 33 (4):1154-1155. Epub 03/07/2021.

Mortality benefits of thromboprophylaxis - Authors' reply.

Klemen ND, Feingold PL, Hashimoto B, Gross CP, Pei KY

The Lancet. Haematology.. 2020 November 7 (11):e783-e784. Epub 1900 01 01.

Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis.

Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, Gross CP, Pei KY

The Lancet. Haematology.. 2020 August 7 (8):e583-e593. Epub 1900 01 01.

Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.

Xu Y, Surman DR, Diggs L, Xi S, Gao S, Gurusamy D, McLoughlin K, Drake J, Feingold P, Brown K, Wangsa D, Wangsa D, Zhang X, Ried T, Davis JL, Hernandez J, Hoang CD, Souza RF, Schrump DS, Taylor Ripley R

Oncogene.. 2020 January 39 (4):877-890. Epub 09/30/2019.

Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.

Klemen ND, Wang M, Feingold PL, Cooper K, Pavri SN, Han D, Detterbeck FC, Boffa DJ, Khan SA, Olino K, Clune J, Ariyan S, Salem RR, Weiss SA, Kluger HM, Sznol M, Cha C

Journal for immunotherapy of cancer.. 2019 July 247 (1):196. Epub 07/24/2019.

Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.

Feingold PL, Surman DR, Brown K, Xu Y, McDuffie LA, Shukla V, Reardon ES, Crooks DR, Trepel JB, Lee S, Lee MJ, Gao S, Xi S, McLoughlin KC, Diggs LP, Beer DG, Nancarrow DJ, Neckers LM, Davis JL, Hoang CD, Hernandez JM, Schrump DS, Ripley RT

Molecular cancer therapeutics.. 2018 September 17 (9):2013-2023. Epub 06/22/2018.

Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.

Feingold PL, Klemen ND, Kwong MLM, Hashimoto B, Rudloff U

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.. 2018 August 34 (5):501-511. Epub 12/07/2017.

Temporal Variations in Pediatric Trauma: Rationale for Altered Resource Utilization.

Groh EM, Feingold PL, Hashimoto B, McDuffie LA, Markel TA

The American surgeon.. 2018 June 184 (6):813-819. Epub 1900 01 01.

Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.

Xu Y, Feingold PL, Surman DR, Brown K, Xi S, Davis JL, Hernandez J, Schrump DS, Ripley RT

Oncotarget.. 2017 November 248 (60):101057-101071. Epub 11/10/2017.

Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.

Feingold PL, Kwong ML, Davis JL, Rudloff U

Journal of surgical oncology.. 2017 February 115 (2):192-201. Epub 11/23/2016.

Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.

Klemen ND, Feingold PL, Goff SL, Hughes MS, Kammula US, Yang JC, Schrump DS, Rosenberg SA, Sherry RM

Annals of surgical oncology.. 2017 January 24 (1):135-141. Epub 09/16/2016.

Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience.

Feingold PL, Quadri HS, Steinberg SM, Malech HL, Gallin JI, Zerbe CS, Zarember KA, Marciano BE, Holland SM, Schrump DS, Ripley RT

Journal of clinical immunology.. 2016 October 36 (7):677-83. Epub 08/06/2016.

Long-term survival following in-hospital cardiac arrest: A matched cohort study.

Feingold P, Mina MJ, Burke RM, Hashimoto B, Gregg S, Martin GS, Leeper K, Buchman T

Resuscitation.. 2016 February 99 :72-8. Epub 12/17/2015.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?

Feingold PL, Kwong ML, Sabesan A, Sorber R, Rudloff U

Journal of gastrointestinal oncology.. 2016 February 7 (1):87-98. Epub 1900 01 01.

Outcomes data in pain studies: in reply to Barbul and colleagues.

Master VA, Watkins AA, Johnson TV, Shrewsberry AB, Nourparvar P, Madni T, Watkins CJ, Feingold PL, Kooby DA, Maithel SK, Staley CA

Journal of the American College of Surgeons.. 2015 March 220 (3):375. Epub 1900 01 01.

Ice packs reduce postoperative midline incision pain and narcotic use: a randomized controlled trial.

Watkins AA, Johnson TV, Shrewsberry AB, Nourparvar P, Madni T, Watkins CJ, Feingold PL, Kooby DA, Maithel SK, Staley CA, Master VA

Journal of the American College of Surgeons.. 2014 September 219 (3):511-7. Epub 05/23/2014.

Feasibility and economic impact of dedicated hospice inpatient units for terminally ill ICU patients.

Binney ZO, Quest TE, Feingold PL, Buchman T, Majesko AA

Critical care medicine.. 2014 May 42 (5):1074-80. Epub 1900 01 01.

Routine intraoperative frozen section analysis of bronchial margins is of limited utility in lung cancer resection.

Owen RM, Force SD, Gal AA, Feingold PL, Pickens A, Miller DL, Fernandez FG

The Annals of thoracic surgery.. 2013 June 95 (6):1859-65; discussion 1865-6. Epub 02/14/2013.

Nocturnal violence: implications for resident trauma operative experiences.

Watkins CJ, Feingold PL, Hashimoto B, Johnson LS, Dente CJ

The American surgeon.. 2012 June 78 (6):657-62. Epub 1900 01 01.

Anti-drug abuse commercials.

Feingold PC, Knapp ML

The Journal of communication.. 1977 27 (1):20-8. Epub 1900 01 01.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.